Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 4 de 4
Add filters

Year range
Article in English | WPRIM | ID: wpr-880499


Radix Astragali (RA), a traditional Chinese medicine from the dried root of Astragalus species, is widely distributed throughout the temperate regions of the world. The major bioactive constituents of RA are triterpene glycosides, flavonoids, saponins, and alkaloids, and these compounds mostly exert pharmacological activities on the cardiovascular, immune, respiratory, and hepatic systems. This review summarizes the recent studies on RA and provides a comprehensive summary regarding the status of resources, ethnopharmacology, phytochemistry, pharmacology, toxicology, clinical application, and patent release of RA. We hope this review can provide a guidance for further development of therapeutic agents from RA.

Article in Chinese | WPRIM | ID: wpr-873138


" Basaga" is one of the commonly used medicinal materials in Mongolian medicine. It has a long history and effects in cooling blood, stopping stabbing pain and detoxifying. The " Basaga" in Mongolian medicine compound preparations have been widely used in various Mongolian hospitals because of its remarkable clinical efficacy. However, due to the differences in inheritance, medicinal parts and plants in Inner Mongolia, the phenomena of homonym and synonym in the application of " Basaga" have been very obvious, which leads to confusion in clinical use, and challenges the safety and effectiveness of this kind of Mongolian medicine. To understand the application of " Basaga" in Mongolian medicine compound preparation, and collect and summarize the types of " Basaga" preparations and the variety of " Basaga" used in preparations and formulations, functional indications and clinical applications were analyzed and collected based on standards and specifications of Mongolian medicine, the application of Mongolian medicine hospitals and Mongolian medicine hospital' s preparation room in Inner Mongolian, and relevant documents in recent years were reviewed. The data can provide references for optimizing and improving " Basaga" , Mongolian medicine standards and the overall standard level. What' s more, the basic data for strengthening the comprehensive development and research of " Basaga" in Mongolian medicine compound preparations in future, so as to ensure and improve the accuracy and clinical effectiveness of " Basaga" in prescriptions of Mongolian patent medicine, and lay a foundation for rational use and modern research of " Basaga" Mongolian medicine.

Article in Chinese | WPRIM | ID: wpr-828021


The epidemic situation of coronavirus disease 2019(COVID-19) is developing rapidly in the world, and the influence is serious. In this study, the prescription of Mongolian medicine to prevent new type of COVID-19 was investigated. Based on the second edition and the third edition of COVID-19 Mongolian Medicine Prevention and Treatment Guidance Program issued by the Inner Mongolia Autonomous Region Health Commission, using Excel 2007, SPSS Modeler 18, SPSS Statistics 25, Cytoscape 3.7.1 statistical software as a tool, the association rules analysis and cluster analysis of Mongolian medicine included in the standard were carried out. Among the 45 prophylactic prescriptions included in the standard, a total of 34 high-frequency drugs using frequency ≥5 were used, of which Carthami Flos(21 times, 4.46%), Chebulae Fructus(20 times, 4.26%), Moschus(13 times, 2.77%), Myristicae Semen(12 times, 2.55%), Santali Albi Lignum(12 times, 2.55%), and Bovis Calculus(12 times, 2.55%) were the most common. The main drugs for the prevention of COVID-19 were Liang(13 times, 38.23%), Wen(9 times, 26.47%), the flavor was Ku(20 times, 34.48%), Xin(13 times, 22.41%), Gan(11 times, 18.97%), the most used drugs treating hot evil(99 times, 32.46%), treatment of "Heyi" drugs(51 times, 16.72%), treatment of "Badagan" drugs(40 times, 13.11%), treatment of "sticky" drugs(37 times, 12.13%), and a cough, eliminating phlegm and antiasthmatic(31 times, 10.16%), the association rule analysis found that the highest association intensity of the drug pair combination of 11. Clustering analysis using the cluster analysis of inter-group join method found a total of 8 categories. In this study, 45 prescriptions of Mongolian medicine for the prevention of COVID-19 were collec-ted and further analyzed, hoping to provide new ideas for clinical diagnosis and treatment.

Betacoronavirus , China , Coronavirus Infections , Drug Therapy , Humans , Medicine, Mongolian Traditional , Pandemics , Pneumonia, Viral , Drug Therapy
Article in Chinese | WPRIM | ID: wpr-271318


<p><b>OBJECTIVE</b>To observe the effect mechanisms of mild moxibustion in treatment of hyperlipidemia.</p><p><b>METHODS</b>Sixty SD rats were randomly divided into a normal group, a model group, a moxibustion group, an acupuncture group and a medication group, 12 rats in each group. The hyperlipidemia model was established by intro-gastric administration of fat emulsion for 4 weeks in the later four groups, and 0.9% sodium chloride was given in the normal group. Treatments started when hyperlipidemia model was sullessfully established. No treatment was given in the normal group and the model group. The acupuncture group and the moxibustion group were treated with acupuncture and moxibustion at Zusanli (ST 36) and Shenque (CV 8), respectively, once a day. The medication group was treated with introgastric administration of lovastatin (10 mg/kg), once a day. The model group, acupuncture group, moxibustion group and medication group were treated with continuing introgastric administration during the 4-week treatment. Four blood lipoids items were detected by biochemical colorimetry, and the contents of serum NO were measured by nitrate reductase method.</p><p><b>RESULTS</b>Compared with the model group, the contents of serum total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL-C) and NO in the moxibustion group, acupuncture group and medication group were decreased (P < 0.01, P < 0.001), mean-while, high-density lipoprotein cholesterol (HDL-C) showed a increasing trend without statistical significance. The moxibustion group was better than the medication group at the effect in decreasing the contents of TC, LDL-C and NO. NO had positive correlation with TC and LDL-C in the moxibustion group (P < 0.05, P < 0.01), while NO had negative correlation with TC and LDL-C in the medication group (both P < 0.01).</p><p><b>CONCLUSION</b>Mild moxibustion has a favorable regulative action on blood lipoids and serum NO in hyperlipidemia rats. Mild moxibustion can play a role in anti-vascular injury, anti-inflammation and prevention of atherosclerosis by lowering the serum NO in rats.</p>

Animals , Cholesterol , Blood , Cholesterol, HDL , Blood , Humans , Hyperlipidemias , Blood , Therapeutics , Male , Moxibustion , Nitric Oxide , Blood , Rats , Rats, Sprague-Dawley , Triglycerides , Blood